These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30395829)

  • 1. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
    Ni W; Li Z; Liu Z; Ji Y; Wu L; Sun S; Jian X; Gao X
    J Pharm Sci; 2019 Mar; 108(3):1284-1295. PubMed ID: 30395829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly simulation and synergistic chemotherapy of TPGS derivative functionalized polymersomes in hepatocellular carcinoma.
    Liu T; Deng Y; Yao J; Xiong H; Yao J
    Nanomedicine (Lond); 2019 Jul; 14(13):1707-1727. PubMed ID: 31298079
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
    Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
    Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
    Chen D; Pan X; Xie F; Lu Y; Zou H; Yin C; Zhang Y; Gao J
    Int J Nanomedicine; 2018; 13():6855-6870. PubMed ID: 30498347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
    Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
    Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.
    Ning Q; Liu YF; Ye PJ; Gao P; Li ZP; Tang SY; He DX; Tang SS; Wei H; Yu CY
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10578-10588. PubMed ID: 30802029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
    Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
    Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Drug Loaded Nanobubbles Combined with Sonodynamic and Chemotherapy for Hepatocellular Carcinoma Therapy.
    Guo T; Wang Y; Chen D; Cui S; Guo S; Feng Y; Zhu J; Chang L; Zhang J; Gao X; Wei X
    Int J Nanomedicine; 2024; 19():7367-7381. PubMed ID: 39050872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO
    Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J
    Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotinylated polyaminoacid-based nanoparticles for the targeted delivery of lenvatinib towards hepatocarcinoma.
    Varvarà P; Emanuele Drago S; Esposito E; Campolo M; Mauro N; Calabrese G; Conoci S; Morganti D; Fazio B; Giammona G; Pitarresi G
    Int J Pharm; 2024 Sep; 662():124537. PubMed ID: 39079592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.
    Cao H; Wang Y; He X; Zhang Z; Yin Q; Chen Y; Yu H; Huang Y; Chen L; Xu M; Gu W; Li Y
    Mol Pharm; 2015 Mar; 12(3):922-31. PubMed ID: 25622075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
    Wen J; Lv Y; Xu Y; Zhang P; Li H; Chen X; Li X; Zhang L; Liu F; Zeng W; Sun S
    Acta Biomater; 2019 Jan; 83():359-371. PubMed ID: 30414486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
    Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y
    Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.